Bumed

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bumed

Bumed is a synthetic medicinal preparation characterized by the active ingredient Ibuprofen, serving as a widely recognized agent for symptomatic relief from general aches and discomfort. The specific formulation of Bumed is typically positioned as an Over-the-counter (OTC) single-ingredient product, making it readily available for managing minor ailments.

Property Description
Active ingredient Ibuprofen
Form Tablet, capsule, liquid suspension
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Relief of pain, inflammation, and fever
Origin Synthetic (Propionic acid derivative)

What Type of Medicine is Bumed?

Bumed belongs to the high-level pharmacological class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a major category of medications used to alleviate pain and reduce inflammation. The active ingredient, Ibuprofen, is classified chemically as a propionic acid derivative, which defines its synthetic origin. Bumed is clinically recognized for its versatility in providing general relief, making it a foundational component of many home medicine cabinets.

The Active Ingredient and General Purpose

The sole active ingredient in Bumed is Ibuprofen, which delivers its primary benefits as an analgesic (pain reliever), an antipyretic (fever reducer), and an anti-inflammatory agent. This triple-action profile is associated with effectiveness across a broad range of symptomatic discomfort. Ibuprofen serves as an agent for the reduction of fever and various types of mild-to-moderate pain. The medicine helps ease discomfort and lower body temperature when elevated, making Bumed a typical choice for general relief, such as when experiencing a headache or muscle soreness.

Composition and Available Forms

The overall composition of Bumed includes the active substance Ibuprofen combined with various non-active pharmaceutical excipients necessary to create the final stable preparation. The finished drug entity is produced in distinct dosage forms for oral route of administration, including solid forms like the tablet and capsule, and liquid preparations such as a suspension. These different drug forms use varying base/vehicle components to ensure suitability across diverse patient groups.

Regulatory References

  1. National Institutes of Health

What side effects are possible with Bumed?

The safety profile for pharmaceuticals and medical materiel under the purview of the Bureau of Medicine and Surgery (BUMED) is governed by specific regulatory frameworks that prioritize the reporting and classification of severe events.

Safety Classifications

The most critical risks are categorized through the Medical Materiel Complaint System.

Classification Definition of Harm
Category I Materiel that predictably could cause or has resulted in serious injury, illness, or loss of life due to failure, malfunction, or labeling issues.
Adverse Drug Reactions (ADR) Any noxious and unintended response to a medication that occurs at doses normally used in humans for prophylaxis, diagnosis, or therapy.

Key Safety Monitoring and Restrictions

Official regulatory documents require mandatory reporting for any event resulting in death, serious injury, or illness caused by medical devices or materiel. This reporting requirement ensures continuous post-market surveillance of product safety within the system.

A particular safety limitation exists for operational personnel, such as Aviation Personnel. Mandatory temporary grounding or removal from duty is imposed when initiating nearly all medications, including certain approved antibiotics, to assess for adverse side effects or unpredictable reactions that could compromise critical operational safety. This restriction is a key component of the overall safety management strategy, focusing on risk mitigation in high-consequence environments. The regulatory framework separates risks into those from the drug's action and those from the product's quality.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Bumed (Ibuprofen) is formally documented in regulatory sources and requires immediate medical attention. Manifestations commonly involve the Gastrointestinal (GI) system, presenting as nausea, vomiting, abdominal pain, and diarrhea. Central Nervous System (CNS) effects are also documented, including drowsiness, dizziness, severe headache, confusion, and ringing in the ears (tinnitus).

A severe overdose may lead to life-threatening outcomes affecting major organ systems. These include severe CNS depression escalating to coma, seizures, and respiratory depression. Serious systemic complications like acute renal failure, hepatic failure, and significant low blood pressure (hypotension) are also described in official labeling.

Mandatory Emergency Actions Regulatory guidance explicitly states that if an overdose is suspected, an individual must seek immediate medical help or contact a Poison Control Center right away. Emergency services should be contacted for any severe symptoms, such as difficulty breathing or loss of consciousness.

Management and Risk No specific antidote for Bumed overdose is known. Management is described as strictly symptomatic and supportive, often requiring hospital observation and continuous monitoring of vital signs and laboratory measures. Regulator-documented population-specific considerations note increased risk for severe complications in children following massive ingestions and greater risk of renal and GI issues in elderly patients.

Therapeutic Uses of Bumed

Bumed (Ibuprofen) is commonly used to help with symptoms related to physical discomfort, offering broad symptomatic support across several key domains. It is applied when supportive symptom management is appropriate, assisting patients by addressing pain, fever, and inflammation. The medication is relevant in conditions where symptoms may intensify temporarily, such as tension headaches, general muscle soreness, toothache, menstrual cramps, and symptomatic flare-ups of arthritis.

An important context regarding its use is often related to:

“Bumed helps address symptom clusters that may become intense or disruptive, providing supportive relief when symptoms interfere with routine activities.”

Symptom Management Domains

Bumed is relevant in clinical settings that involve acute or disruptive symptom patterns, including the management of fever and systemic aches associated with the common cold or influenza, and the relief of mild-to-moderate pain. It is also applicable in scenarios where additional management of discomfort is required for symptoms related to inflammatory or irritative states, such as localized swelling or tenderness from minor strains. This supports general well-being during symptomatic phases.

Quick Fact: Relief for Pain and Fever
Contributes to easing the overall symptom load related to headache, backache, and muscular aches, while also supporting the reduction of elevated body temperature.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Bumed?

Bumed (Ibuprofen) eligibility is strictly defined by regulatory documents, focusing on populations for whom use is prohibited or restricted. The medicine is generally permitted for adults and teenagers who have no contraindications. Use is also established in children six months of age and older, though infants below this age threshold are not approved due to insufficient safety data. Elderly patients (60 years and older) should use this medicine with caution due to a higher documented risk of adverse effects.


Absolute Prohibitions

The following populations must not use Bumed:

  • Individuals with a known hypersensitivity to Ibuprofen, Aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID).
  • Patients diagnosed with severe heart, hepatic, or renal failure.
  • Patients with active or a history of recurrent gastrointestinal bleeding or ulcers.
  • Women during the last trimester of pregnancy or immediately before/after heart (CABG) surgery.

Conditional Use

Use requires careful consideration or caution in these groups:

  • Patients with mild-to-moderate renal or hepatic impairment.
  • Individuals with uncontrolled hypertension or established cardiovascular disease (e.g., specific heart failure classes).
  • Patients with a history of Crohn’s Disease or asthma, as use may exacerbate these conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Bumed, which contains the active ingredient Ibuprofen, has officially documented interaction profiles, primarily concerning effects on bleeding risk and the exposure levels of co-administered medicines.

Contraindicated and High-Risk Combinations

Classification Interacting Agents Officially Documented Effect
Contraindicated Other NSAID products (including COX-2 selective inhibitors) Increased risk of serious adverse events, including ulceration and bleeding.
Contraindicated Peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery Formal prohibition for use.
High-Risk Anticoagulants (e.g., Warfarin) and Oral Corticosteroids Pharmacodynamic synergism increases the risk of severe gastrointestinal bleeding and ulceration.

Exposure and Effectiveness Modifications

Bumed can alter the plasma concentrations of certain drugs by reducing their renal clearance. This interaction may result in increased blood levels and potential toxicity for medicines such as Lithium and Methotrexate.

For low-dose Aspirin taken for cardioprotection, regulatory information notes that Ibuprofen may interfere with its antiplatelet effect, necessitating specific timing separation to avoid antagonism of the intended benefit.

Interactions with antihypertensive agents, including ACE Inhibitors, ARBs, and Diuretics, may reduce the effectiveness of these blood pressure-lowering medicines and formally increase the risk of nephrotoxicity.

Other Regulatory Considerations

The interaction profile includes warnings that the risk of serious gastrointestinal bleeding is formally heightened by the consumption of three or more alcoholic drinks every day. Furthermore, the risk of serious GI and renal adverse events is specifically noted to be greater in elderly patients (age 60 or older) when Bumed is co-administered with interacting agents.

Mechanism of Action

The action of Bumed (Ibuprofen) is defined by its core mechanism of reversible competitive inhibition of the Cyclooxygenase (COX) enzymes, which are key regulators of the body's lipid signaling pathways. This molecular intervention produces physiological modulation across central and peripheral systems.

Inhibition of Inflammatory Mediator Synthesis

This domain covers the drug's primary targets, COX-1 and COX-2, which are responsible for converting arachidonic acid into prostanoids. By blocking these enzymes, the formation of critical local signaling molecules, particularly Prostaglandin E2 (PGE2), is drastically reduced. This suppression of the mediator cascade results in a reduction of signaling intensity within the affected pathways.

Dual Modulation of Central and Peripheral Signaling

The resulting scarcity of PGE2 acts on two main systems simultaneously. Peripherally, the mechanism raises the necessary threshold for nociceptors (pain-sensing nerves) to transmit signals. Centrally, the lack of PGE2 within the hypothalamus allows the thermoregulatory set-point to normalize.

Mechanistic Limitation of Effect Duration

The interaction of Bumed with the COX enzymes is reversible, meaning the drug's effect is temporary and enzyme activity is restored once the concentration falls below the inhibitory threshold. This mechanistic limitation defines the drug's duration of action, influencing the speed at which the affected pathways return to their baseline activity.

Dosage and Administration Information

How to Use Bumed: Official Administration Guidelines

The standardized use of Bumed is governed by specific instructions, primarily authorizing the oral administration route via available forms like tablets, capsules, and suspensions. The intravenous route is only approved for specific applications within supervised hospital settings.

For general, over-the-counter use, the typical oral dose is 200 mg to 400 mg, taken every 4 to 6 hours as necessary. The maximum total daily dose for self-medication is strictly limited to 1,200 mg. In contrast, prescription regimens for chronic conditions can involve higher single doses, with the maximum daily dose reaching 3,200 mg, divided into multiple administrations throughout the day.

In terms of administration context, the medication may be taken with food or milk to potentially ease gastrointestinal discomfort. For the liquid suspension form, official labeling requires that the container be shaken well before use and the dose accurately measured with the provided device.

Official instructions limit the duration of self-medication to a maximum of 10 days for pain and 3 days for fever. Use extending beyond these timeframes, such as the long-term, continuous courses seen in managing chronic conditions, is governed by prescription. Dosage for children is calculated based on body weight (mg/kg), rather than a fixed amount, adhering to population-specific administration rules.

Recent Clinical Evidence

Research evidence / Overview of studies for Bumed

Evidence for Acute Mild-to-Moderate Pain

Research exploring the use of Bumed for general, short-term physical discomfort is built upon a large number of Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews. These studies primarily measure outcomes related to physical discomfort over defined, short time intervals, often comparing Bumed against an inactive substance (placebo). The populations studied included adults with pain following defined procedures or related to musculoskeletal discomfort.

Studies monitored and documented how symptoms evolved in the observed populations, specifically focusing on measured changes in pain intensity over defined observation periods. These findings describe patterns observed in the studies regarding the fraction of participants who achieved a certain measured relief threshold within a specified time window. What remains uncertain is the applicability of these short-term results to every possible scenario of acute discomfort, as follow-up durations were limited.


Evidence for Fever Reduction (Antipyresis)

The research has widely evaluated Bumed’s use in studies examining outcomes related to systemic or functional imbalance, including measurements of body temperature. The evidence structure includes numerous RCTs and Systematic Reviews that explored this use, including those that compared measurements against other studied agents. The research has examined these changes in both children (pediatric patients) and adults experiencing fever.

In these studies, researchers monitored outcomes describing episodic or acute changes in body temperature, including the time taken for the temperature to change and the measured duration of this change. Consistency was documented across many of the examined populations. This means that the long-term effects are not fully established regarding symptom patterns over extended periods, and the results apply only to the populations studied and the defined timeframes of the research.


What Is Still Uncertain About Bumed

Scientific literature consistently describes limitations and gaps within the evidence base for Bumed. For acute symptom management, the follow-up durations were limited, focusing mainly on the first 24 hours of relief. The subgroup findings are uncertain in many cases, as not all specific comorbidity or patient groups have been sufficiently powered in the main efficacy RCTs. In general, the research primarily describes outcomes related to physical discomfort and temporary symptom control, and comparative evidence is lacking for some of the less common uses.

Key Studies & References

  1. Ibuprofen: MedlinePlus Drug Information (Common uses and symptomatic management)
  2. Ibuprofen: StatPearls - NCBI Bookshelf (Confirmation of triple-action profile and efficacy reviews)

Frequently Asked Questions (FAQ)

Common questions about Bumed (FAQ)


Q: How long does a dose of Bumed usually last in the body?

Official product instructions for Bumed advise a dosing interval of every four to six hours for short-term use. This range is consistent with how long the medicine's temporary effect on the body is typically observed. Its action is reversible, meaning the drug's activity subsides, and the activity of the systems it affects is restored after a few hours.


Q: Is it necessary to take Bumed every day?

Whether Bumed must be taken daily depends on the type of use. For over-the-counter administration addressing sudden or acute symptoms, the medication is typically taken only as needed, according to the official limits. Long-term, continuous courses of use, such as for managing chronic conditions, are administered under prescription and guidance from a prescribing professional.


Q: What foods or drinks should be avoided while taking Bumed?

Regulatory warnings specifically advise that consuming three or more alcoholic drinks every day can heighten the risk of serious gastrointestinal bleeding when using this medication. Otherwise, official information states that Bumed may be taken with food or milk, which is sometimes recommended to ease any stomach discomfort.


Q: Can I take Bumed with other over-the-counter medications?

Regulatory documents strongly caution against combining Bumed with other over-the-counter pain relievers, particularly those containing other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This includes other Ibuprofen products or those containing naproxen. Official warnings also note specific risks when taking Bumed alongside products that contain acetaminophen.


Q: What should I do if a side effect feels severe?

Official warnings indicate that immediate cessation of use is necessary if serious events are experienced, such as a severe allergic reaction, symptoms of stomach bleeding, or signs of liver or kidney problems. Seeking professional medical help right away is warranted for any severe or concerning symptoms.


Q: What is the average length of time people stay on Bumed?

The official instructions limit self-medication to a maximum of ten days for pain and three days for fever relief. For prescribed use in chronic conditions, official labeling does not define a single 'average' length of time. The duration of therapy for long-term conditions is established under the supervision of a prescribing health professional.


Q: If I feel better, can I just stop taking Bumed?

For short-term, over-the-counter use, the medication is taken only as necessary to manage symptoms, implying that use can be stopped once the symptoms subside. If the medication has been prescribed for long-term administration, official guidance indicates that any changes, including stopping the use or reducing the dose, is typically managed under the guidance of the prescribing health professional.


Q: Is Bumed widely available in pharmacies?

The active ingredient in Bumed, Ibuprofen, is widely classified as an Over-the-counter (OTC) medicine by regulatory bodies. This classification means the product is generally available for purchase without a prescription in pharmacies and other authorized retail locations.


Q: What is the risk of an allergic reaction to Bumed?

Official warnings indicate that Ibuprofen may cause a severe allergic reaction, particularly in individuals with a known allergy to aspirin or other NSAIDs. Symptoms associated with this risk include hives, facial swelling, wheezing, and skin reactions such as blisters or rashes.


Q: What happens to Bumed in the body after it has exerted its effect?

After Bumed has exerted its effect, the active ingredient is processed by the liver in a process called metabolism. It is converted into compounds that are inactive, meaning they no longer have a therapeutic effect. These inactive compounds are then rapidly and completely eliminated from the body, primarily through the kidneys.


Q: How quickly does Bumed start to work for most people?

Studies examining the onset of action indicate that certain forms of the medicine may begin working within 30 minutes of administration. However, official information notes that a measured and noticeable reduction in symptoms like pain or fever may take up to two hours for most people.


Q: Can Bumed affect my ability to drive or operate machinery?

Regulatory warnings note that Bumed can cause side effects such as dizziness or drowsiness. Because of this, activities requiring full alertness, such as driving or operating machinery, should be avoided until an individual is certain they can do so safely and without impairment.


Q: What are some of the most common side effects reported with Bumed?

According to official product information, common side effects reported often include mild gastrointestinal symptoms, such as stomach upset, nausea, or diarrhea. Other frequently reported effects include headache and dizziness.


Q: Can Bumed cause changes in mood or sleep?

Official documentation indicates that potential side effects associated with Bumed include drowsiness, which may affect normal sleep patterns. In rare instances, official regulatory reports have also included certain changes in mental or mood status.


Q: Is there a risk of dependence or addiction with Bumed?

Bumed, as a single-ingredient Nonsteroidal Anti-inflammatory Drug (NSAID), is not classified as a controlled substance by government regulatory bodies. Official product documentation does not identify a risk of dependence or addiction for this specific formulation.


Q: Is Bumed available as a generic version?

The active ingredient in Bumed is Ibuprofen, which is an established medicine with a long history of use. According to regulatory records, Ibuprofen is widely available in generic form under multiple different manufacturer labels and brand names.


Q: Is it normal to feel tired when first starting Bumed?

Official product information indicates that drowsiness and fatigue are listed as possible side effects. These effects may sometimes be experienced when first starting the medication, according to regulatory sources.


Q: What is known about using Bumed while breastfeeding?

Official regulatory labeling notes that because many drugs are excreted in human milk, a determination should be reached regarding whether to discontinue nursing or discontinue the use of the drug. This requires careful consideration of the importance of the drug to the mother and potential exposure to the infant.


Q: Does Bumed have a Black Box Warning?

Yes, the official FDA prescribing information for the active ingredient in Bumed contains a Boxed Warning. This warning highlights the potential for serious cardiovascular thrombotic events such as heart attack or stroke. It also addresses the potential for serious gastrointestinal adverse events, including bleeding, ulceration, and perforation.


Q: What information should I read before starting Bumed?

Official product labeling states that the Medication Guide or Patient Information Leaflet supplied with the medicine should be read. Regulatory agencies mandate that this documentation be reviewed before starting the medication and upon each refill of a prescription.


Q: Can Bumed be split or crushed to make it easier to swallow?

Official administration instructions vary depending on the specific formulation (e.g., tablet, capsule, extended-release). While general guidance may allow some standard tablets to be split, regulatory documents often specify that certain formulations, such as those with special coatings or extended-release properties, are not intended to be crushed, chewed, or divided.


Q: Why are the use conditions for Bumed so strict?

The specific conditions, limitations on dose, and duration of use are established to help mitigate documented risks of serious adverse events. These measures are designed to reduce the potential for serious cardiovascular thrombotic events (like heart attack or stroke) and serious gastrointestinal adverse events (like bleeding and ulcers), as highlighted in official warnings.


Q: Are there common lifestyle changes that accompany the use of Bumed?

Official warnings describe an increased risk of serious gastrointestinal bleeding for individuals who consistently consume three or more alcoholic drinks daily while using the medicine. Furthermore, regulatory documents caution against driving or operating machinery if the patient experiences side effects like dizziness or drowsiness.


Q: What kind of monitoring is recommended when taking Bumed?

Official prescribing information indicates that for patients taking Bumed long-term, close monitoring of blood pressure is recommended. Depending on the regimen and individual factors, monitoring for signs of early liver dysfunction or changes in kidney function may also be advised.


Q: Do regulatory bodies classify Bumed as a controlled substance?

Bumed is a single-ingredient Nonsteroidal Anti-inflammatory Drug (NSAID). According to the Drug Enforcement Administration (DEA) and other government agencies, this specific medicine is not classified as a controlled substance.


Q: Are there any common misuses of Bumed that people should be aware of?

Official warnings document the increased risk associated with exceeding the directed dosage. Regulatory documents strongly caution against two specific high-risk actions: combining Bumed with other nonsteroidal anti-inflammatory drugs (NSAIDs) and consistently consuming alcohol while on the medication, as both actions significantly increase the risk of serious adverse events.

How should Bumed be stored and disposed of?

Storage and Disposal of Bumed (Ibuprofen)

Official regulatory documents mandate specific storage and handling conditions to maintain product stability and integrity.

Required Storage Conditions

Bumed must be stored at Controlled Room Temperature (CRT), defined as 20 C to 25 C (68 F to 77 F), with temporary excursions permitted. It must be kept in its original container, which should remain tightly closed when not in use. It is a mandatory requirement that the medicine be stored out of the sight and reach of children.

Handling and Protection

The product must be protected from excessive moisture and light. The label strictly states that the medicine must not be frozen. Some oral liquid forms may have specific stability periods after the bottle is first opened, which must be adhered to.

Disposal Instructions

Unused or expired Bumed must not be disposed of via wastewater (flushed down a drain). The preferred method for disposal is using a drug take-back program. Otherwise, the medication should be mixed with an undesirable substance, sealed in a bag, and then discarded according to local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bumed found in:

A-Z Index: